Beaumont Hosting Community BRCA Cancer Conference
Nov. 30 symposium is for women and men at risk for cancer from BRCA 1 or 2 genetic mutations
Genetic testing can help determine a person’s risk for developing certain cancers. Identifying cancer genes, the presence of BRCA 1and 2 mutations, is the first step. This testing allows the implementation of risk-reducing interventions: more frequent screening, surgical prevention and chemoprevention. For patients and families at risk for hereditary breast and ovarian cancer due to BRCA mutations, the information gained from genetic testing not only provides answers, but raises questions, too. On Nov. 30, Beaumont Health System is hosting Michigan’s first day-long conference for these area residents seeking information and support. While there are no fees to attend the symposium, registration is required. To register, call 800-633-7377 or…
